Mail

UK markets open in 7 hours 56 minutes

NIKKEI 225
38,835.10
+599.03(+1.57%)
HANG SENG
18,479.37
-98.93(-0.53%)
CRUDE OIL
78.37
-0.01(-0.01%)
GOLD FUTURES
2,323.00
-1.20(-0.05%)
DOW
38,884.26
+31.99(+0.08%)
Bitcoin GBP
50,257.04
-523.19(-1.03%)

The retirement income gap no-one is talking about

People are living longer than ever before and this can impact how you plan for retirement

Capstone Therapeutics Corp. (CAPS)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

5.0000

0.0000

(0.00%)

At close: 10:46AM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	788.05k
Enterprise value	21.06M
Trailing P/E	28.10
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	0.02
Price/book (mrq)	0.32
Enterprise value/revenue	0.44
Enterprise value/EBITDA	-12.04

Trading information

Stock price history

Beta (5Y monthly)	-0.58
52-week change ³	-86.49%
S&P500 52-week change ³	25.77%
52-week high ³	37.0000
52-week low ³	4.9000
50-day moving average ³	5.1960
200-day moving average ³	6.2190

Share statistics

Avg vol (3-month) ³	4
Avg vol (10-day) ³	30
Shares outstanding ⁵	157.61k
Implied shares outstanding ⁶	220.65k
Float ⁸	N/A
% held by insiders ¹	0.00%
% held by institutions ¹	1.13%
Shares short (15 Jul 2011) ⁴	27
Short ratio (15 Jul 2011) ⁴	0.35
Short % of float (15 Jul 2011) ⁴	0.08%
Short % of shares outstanding (15 Jul 2011) ⁴	0.07%
Shares short (prior month 15 Jun 2011) ⁴	33

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	10 Sept 2019
Ex-dividend date ⁴	N/A
Last split factor ²	1:1000
Last split date ³	10 Sept 2019

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2019

Profitability

Profit margin	-7.90%
Operating margin (ttm)	-2.60%

Management effectiveness

Return on assets (ttm)	-1.33%
Return on equity (ttm)	-12.23%

Income statement

Revenue (ttm)	48.35M
Revenue per share (ttm)	306.80
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-950k
Net income avi to common (ttm)	-5.74M
Diluted EPS (ttm)	-36.3900
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	17k
Total cash per share (mrq)	0.11
Total debt (mrq)	3.07M
Total debt/equity (mrq)	N/A
Current ratio (mrq)	1.14
Book value per share (mrq)	15.46

Cash flow statement

Operating cash flow (ttm)	1.45M
Levered free cash flow (ttm)	2.45M